The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Clostridium difficile infection: epidemiology, risk factors and management
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L., & Onderdonk, A. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803092981003 · Cited by 1,374
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Antibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Clostridium difficile Toxins: Mechanism of Action and Role in Disease
Voth, D. E., & Ballard, J. D. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.247-263.2005 · Cited by 1,104
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 904
McFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“A 2006 meta-analysis of the efficacy of probiotics for the treatment of recurrent CDI showed a potential benefit of Saccharomyces boulardii”
MethodEmergence of Clostridium difficile-associated disease in North America and Europe
Kuijper, E. J., Coignard, B., & Tüll, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01580.x · Cited by 855
The Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 826
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
McDonald, L. C., Owings, M., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.051064 · Cited by 788
Teasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Leney, M., Sloan, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 746
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724
Risk factors for Clostridium difficile infection
Bignardi, G. E. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90019-6 · Cited by 647
Goorhuis, A., Bakker, D., Corver, J., Debast, S. B., Harmanus, C., Notermans, D. W., Bergwerff, A. A., Dekker, F. W., & Kuijper, E. J. (2008) · Clinical Infectious Diseases · doi:10.1086/592257 · Cited by 637
Pepin, J. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050978 · Cited by 606
Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection
Owens, Jr., Donskey, C. J., Gaynes, R. P., Loo, V. G., & Muto, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/521859 · Cited by 603
Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577
Impact of Clostridium difficile on Inflammatory Bowel Disease
Issa, M., Vijayapal, A., Graham, M. B., Beaulieu, D. B., Otterson, M. F., Lundeen, S., Skaros, S., Weber, L. R., Komorowski, R. A., Knox, J. F., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.028 · Cited by 570
Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
Pepin, J., Alary, M.-E., Valiquette, L., Raiche, E., Ruel, J., Fulop, K., Godin, D., & Bourassa, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430315 · Cited by 570
Clinical Recognition and Diagnosis of Clostridium difficile Infection
Bartlett, J. G., & Gerding, D. N. (2008) · Clinical Infectious Diseases · doi:10.1086/521863 · Cited by 527
Wenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A. M., & Graninger, W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.813 · Cited by 505
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole
Musher, D. M., Aslam, S., Logan, N., Nallacheru, S., Bhaila, I., Borchert, F., & Hamill, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/430311 · Cited by 504
Ananthakrishnan, A. N., McGinley, E. L., & Binion, D. G. (2008) · Gut · doi:10.1136/gut.2007.128231 · Cited by 426
Self-citationClostridium difficile Infection
Kelly, C. P., & LaMont, J. T. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.375 · Cited by 420
Crobach, M. J. T., Dekkers, O. M., Wilcox, M. H., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03098.x · Cited by 413
Clostridium difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30141083 · Cited by 398
Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
Johnson, S. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.03.010 · Cited by 397
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
Garey, K. W., Sethi, S., Yadav, Y., & DuPont, H. L. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.08.012 · Cited by 376
A case-control study of community-associated Clostridium difficile infection
Wilcox, M. H., Mooney, L., Bendall, R., Settle, C. D., & Fawley, W. N. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn163 · Cited by 372
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
Aslam, S., Hamill, R. J., & Musher, D. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70215-2 · Cited by 366
Diagnosis and Treatment of Clostridium difficile Colitis
Fekety, R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500010081036 · Cited by 354
Schwan, C., Stecher, B., Tzivelekidis, T., van Ham, M., Rohde, M., Hardt, W.-D., Wehland, J., & Aktories, K. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000626 · Cited by 337
Kim, J., Smathers, S. A., Prasad, P., Leckerman, K. H., Coffin, S., & Zaoutis, T. (2008) · Pediatrics · doi:10.1542/peds.2008-0469 · Cited by 321
Bolton, R. P., & Culshaw, M. A. (1986) · Gut · doi:10.1136/gut.27.10.1169 · Cited by 320
Infection control measures to limit the spread of Clostridium difficile
Vonberg, R.-P., Kuijper, E. J., Wilcox, M. H., Barbut, F., Tüll, P., Gastmeier, P., van den Broek, P. J., Colville, A., Coignard, B., Daha, T., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01992.x · Cited by 314
Johnson, S., Schriever, C., Galang, M., Kelly, C. P., & Gerding, D. N. (2007) · Clinical Infectious Diseases · doi:10.1086/511870 · Cited by 312
Measures to Control and Prevent Clostridium difficile Infection
Gerding, D. N., Muto, C. A., & Owens, Jr. (2008) · Clinical Infectious Diseases · doi:10.1086/521861 · Cited by 311
Fekety, R., Silva, J., Kauffman, C., Buggy, B., & Gunner Deery, H. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90223-4 · Cited by 293
Treatment of Clostridium difficile Infection
Gerding, D. N., Muto, C. A., & Owens, Jr. (2008) · Clinical Infectious Diseases · doi:10.1086/521860 · Cited by 287
Clostridium difficile and inflammatory bowel disease
Issa, M., Ananthakrishnan, A. N., & Binion, D. G. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20500 · Cited by 257
Self-citationClinical Risk Factors for Severe Clostridium difficile–associated Disease
Henrich, T. J., Krakower, D., Bitton, A., & Yokoe, D. S. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1503.080312 · Cited by 215
Barbut, F. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45804-0 · Cited by 211
Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread
Clements, A. C., Magalhães, R. J. S., Tatem, A. J., Paterson, D. L., & Riley, T. V. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70080-3 · Cited by 206
Clayton, E. M., Rea, M. C., Shanahan, F., Quigley, E. M. M., Kiely, B., Hill, C., & Ross, R. P. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.4 · Cited by 202
McPherson, S., Rees, C. J., Ellis, R., Soo, S., & Panter, S. J. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0511-8 · Cited by 201
Wilcox, M. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh176 · Cited by 200
Geric, B., Carman, R. J., Rupnik, M., Genheimer, C. W., Sambol, S. P., Lyerly, D. M., Gerding, D. N., & Johnson, S. (2006) · The Journal of Infectious Diseases · doi:10.1086/501368 · Cited by 196
Historical Perspectives on Studies of Clostridium difficile and C. difficile Infection
Bartlett, J. G. (2008) · Clinical Infectious Diseases · doi:10.1086/521865 · Cited by 188
Review of Current Literature on the Economic Burden of Clostridium difficile Infection
Dubberke, E. R., & Wertheimer, A. I. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/592981 · Cited by 184
McEllistrem, M. C., Carman, R. J., Gerding, D. N., Genheimer, C. W., & Zheng, L. (2005) · Clinical Infectious Diseases · doi:10.1086/427113 · Cited by 173
Coyle, W. J. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0050-4 · Cited by 171
Herpers, B. L., Vlaminckx, B., Burkhardt, O., Blom, H., Biemond‐Moeniralam, H. S., Hornef, M., Welte, T., & Kuijper, E. J. (2009) · Clinical Infectious Diseases · doi:10.1086/599224 · Cited by 164
Treatment of Clostridium difficile-Associated Disease
Leffler, D. A., & LaMont, J. T. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.070 · Cited by 142
Johnson, S., Schriever, C. A., Patel, U. C., Patel, T. C., Hecht, D. W., & Gerding, D. N. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2009.08.004 · Cited by 122
Clostridium difficile Infection in Patients With Ileal Pouch–Anal Anastomosis
SHEN, B., Jiang, Z., FAZIO, V., REMZI, F., RODRIGUEZ, L., BENNETT, A., López, R., Queener, E. Y., & DuPont, H. L. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.021 · Cited by 119
Struggling with recurrent Clostridium difficile infections: is donor faeces the solution?
van Nood, E., Speelman, P., Kuijper, E. J., & Keller, J. J. (2009) · Eurosurveillance · doi:10.2807/ese.14.34.19316-en · Cited by 105
Bauer, M. P., Veenendaal, D., Verhoef, L., Bloembergen, P., van Dissel, J. T., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02853.x · Cited by 100
McFarland, L. V. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32831da7c4 · Cited by 99
Risk factors for the development of fulminant Clostridium difficile colitis
Greenstein, A. J., Byrn, J. C., Zhang, L. P., Swedish, K. A., Jahn, A. E., & Divino, C. M. (2008) · Surgery · doi:10.1016/j.surg.2007.12.008 · Cited by 99
Binary toxin producing Clostridium difficile strains
Rupnik, M., Grabnar, M., & Stare, B. G. (2003) · Anaerobe · doi:10.1016/j.anaerobe.2003.09.002 · Cited by 91
Abougergi, M. S., Broor, A., Cui, W., & Jaar, B. G. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.542 · Cited by 91
The Case for Vancomycin as the Preferred Drug for Treatment ofClostridium difficileInfection
Bartlett, J. G. (2008) · Clinical Infectious Diseases · doi:10.1086/587654 · Cited by 91
Clostridium difficile is no longer just a nosocomial infection or an infection of adults
Pituch, H. M. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70016-0 · Cited by 85
Kelly, C. P. (2009) · JAMA · doi:10.1001/jama.2009.171 · Cited by 85
Surgical aspects of fulminant Clostridium difficile Colitis
Butala, P., & Divino, C. M. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.07.040 · Cited by 82
Drudy, D., Harnedy, N., Fanning, S., O’Mahony, R., & Kyne, L. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01634.x · Cited by 81
Lundeen, S. J., Otterson, M. F., Binion, D. G., Carman, E. T., & Peppard, W. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-006-0022-x · Cited by 81
Clostridium difficile 30 years on: what has, or has not, changed and why?
Gerding, D. N. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70008-1 · Cited by 74
Debast, S. B., Vaessen, N., Choudry, A., Wiegers-Ligtvoet, E. A. J., van den Berg, R. J., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02713.x · Cited by 71
Pépin, J. (2008) · Clinical Infectious Diseases · doi:10.1086/587656 · Cited by 71
Fidaxomicin (OPT-80) for the treatment ofClostridium difficileinfection
Miller, M. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.485614 · Cited by 63
Clostridium Difficile and Inflammatory Bowel Disease
Ananthakrishnan, A. N., Issa, M., & Binion, D. G. (2009) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.07.003 · Cited by 60
Self-citationClostridium difficile: controversies and approaches to management
Bauer, M. P., van Dissel, J. T., & Kuijper, E. J. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833229ce · Cited by 56
Processing of Clostridium difficile toxins
Giesemann, T., Egerer, M., Jank, T., & Aktories, K. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47742-0 · Cited by 56
Hu, M. Y., Maroo, S., Kyne, L., Cloud, J. W., Tummala, S., Katchar, K., Dreisbach, V. C., Noddin, L., & Kelly, C. P. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.06.024 · Cited by 31
Evolving concepts in Clostridium difficile colitis
Diggs, N. G., & Surawicz, C. M. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0060-0 · Cited by 19
Jiang, Z., DuPont, H. L., LaRocco, M., & Garey, K. W. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2008.12.008 · Cited by 8
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Cammarota, G., Masucci, L., Ianiro, G., Bibbò, S., Dinoi, G., Costamagna, G., Sanguinetti, M., & Gasbarrini, A. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13144 · Cited by 558
Antharam, V. C., Li, E. C., Ishmael, A., Sharma, A., Mai, V., Rand, K. H., & Wang, G. P. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00845-13 · Cited by 485
Cammarota, G., Ianiro, G., & Gasbarrini, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000046 · Cited by 428
Metadata
- Authors
- Ananthakrishnan, A. N.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2010-11-30
- Volume
- 8
- Issue
- 1
- Pages
- 17-26
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2004444336
- Cited by
- 352
- References
- 88
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.